The CRC CARE Board has delegated certain powers to the following committees:

• Audit and Risk Management Committee;
• Commercialisation Committee;
• Remuneration Committee;
• Research and Technology Committee.

Audit and Risk Management Committee

The Audit and Risk Management Committee meets at least twice a year to oversee:

• financial reporting procedures, accounting policies and the audited accounts of the Company;
• compliance of the Company with its legal and statutory obligations; and
• management of risk elements faced by the Company.

Membership: Chair: Professor Paul Perkins, Professor Ravi Naidu , Professor Ian Davey, Dr Rod Lukatelich, Nick Mahon

CRC CARE has established a governance structure through its Finance Framework and Finance Policies providing clear operating guidelines for the company (restricted accesss - pasword required).

Commercialisation Committee

The Commercialisation Committee meets regularly during the year and reviews the portfolio of research projects held by the Company with a view to identifying markets and pathways for the commercialisation of intellectual property arising from research expenditure.

Membership: Chair: Mark Hender, Professor Ravi Naidu, Dr Edwin Chan, Professor Jack Ng, Maggie Dowling, Professor Megharaj Mallavarapu, Professor Nanthi Bolan.

Remuneration Committee

The Remuneration Committee meets at least once a year to review the remuneration arrangements for staff and members of the Board of the Company. Two members of the Committee are from the private sector.

Membership: Chair: Professor Paul Perkins, Professor Ravi Naidu, Professor Max Brennan, Dr Rod Lukatelich.

Research and Technology Committee

The Research and Technology Committee reviews research proposals received by the Company and makes recommendations to the Board relating to research expenditure, the quality of research output and the mix of the Company’s research portfolio. It meets twice a year and has 10 members, including four from the private sector. The Committee includes independent persons based in Australia and internationally with technical expertise in the areas of research associated with the activities of the Company.

Membership: Chair: Professor Max Brennan, Professor Ravi Naidu, Dr Rod Lukatelich, Dr Brent Clothier, Professor Gary Pierzynski, Maggie Dowling, Dr Stuart Rhodes, Professor Suresh Rao, Ross McFarland, Jason Clay.

Policy Committee

The role of the Policy Committee is to provide high level, strategic advice to the CRC CARE Board about significant environmental regulatory policy issues, directions, or matters that impinge on, or relate to, the research programs.  The committee also provide a link, and advice, to the Policy Advisory Committee on strategic policy directions for the CRC and maintain strategic communication links and relationships between key stakeholders in the regulatory policy sphere of site contamination, such as the Environment Protection and Heritage Council and National Environment Protection Council.

Membership: Chair: Dr Paul Vogel, Professor Ravi Naidu, Dr Rod Lukatelich, Dr Bruce Kennedy

Policy Advisory Committee

The Policy Advisory Committee meets at least twice a year. Its role is to advise the Managing Director and the Board on policy matters associated with contamination assessment, remediation and management and their potential impact on the operation of the Company, and to highlight areas of research that would benefit the regulatory sphere. The committee has 11 members including two directors and two members from the private sector and members have expertise and interests in the regulation of environmental contamination issues.

Membership: Chair: Dr Bruce Kennedy, Professor Ravi Naidu, Greg O'Brien, Professor Jack Ng, Dr Paul Vogel, Dr Rod Lukatelich, Sharon Clark, Stuart McConnell, Ross McFarland, Mark Donaghey, Stuart Rhodes, Andrew Beveridge, SA EPA, WA DEC. 

Management Committee

The Management Committee is responsible for the day to day operations of the CRC. This committee advises the Board through the Managing Director on research priorities, reports on the monitoring of milestones and performance indicators and ensures effective industry, regulator and stakeholder participation.

Membership: Chair: Professor Ravi Naidu, Professor Jack Ng, Professor Leigh Sullivan, Professor Megharaj Mallavarapu, Professor Nanthi Bolan, Maggie Dowling, Nick Mahon, Peter Martin, Andrew Beveridge.